Injectable Drug Delivery Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Injectable drug delivery market
Injectable Drug Delivery Market: By delivery devices (conventional, self-injection, auto-drug, pen injectors, others); By drug formulations (conventional, novel); By therapeutic areas (auto-immune, hormonal, oncology, others); By Geography - Forecast (2018-2023)
Report Code : HCR 0023
Updated Date: 11 June, 2018  
10

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Injectable drug delivery Market Overview
2. Executive Summary
3. Injectable drug delivery Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis 
      3.2.1. Product Benchmarking
      3.2.2. End User profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Injectable drug delivery Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Injectable drug delivery Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Global Injectable Drug Delivery – Market By Delivery Devices 
   6.1. Market Overview 
   6.2. Conventional Injection Devices Market 
   6.3. Self-Injection Devices Market 
   6.4. Auto Drug Injecting Devices 
      6.4.1. By Drug Loading
            6.4.1.1. Prefilled Auto Injectors 
            6.4.1.2. Fillable Auto Injectors
            6.4.1.3. By User Intervention 
            6.4.1.4. Automated Auto Injectors
            6.4.1.5. Manual Auto Injectors 
            6.4.1.6. By Design 
                     6.4.1.6.1. Standard Auto Injectors 
                     6.4.1.6.2. Customized Auto Injectors 
            6.4.1.7. By Reusability 
                     6.4.1.7.1. Disposable Auto Injectors 
                     6.4.1.7.2. Reusable Auto Injectors 
   6.5. Pen Injectors 
      6.5.1. By Product 
            6.5.1.1. Single Chamber Pen Injectors 
            6.5.1.2. Dual Chamber Pen Injectors 
      6.5.2. By Reusability 
            6.5.2.1. Disposable Pen Injectors 
            6.5.2.2. Reusable Pen Injectors 
      6.5.3. By Design 
            6.5.3.1. Standardized Pen Injectors 
            6.5.3.2. Customized Pen Injectors
   6.6. Needle Free Drug Injection Devices 
      6.6.1. By Drug Loading
            6.6.1.1. Prefilled Needle Free Injectors
            6.6.1.2. Fillable Needle Free Injectors
      6.6.2. By Technology
            6.6.2.1. Jet-Based Needle-Free Injectors
            6.6.2.2. Spring-Based Needle-Free Injectors
            6.6.2.3. Laser-Based Needle Free Injectors
            6.6.2.4. Vibration-Based Needle Free Injectors
      6.6.3. By Reusability
            6.6.3.1. Disposable Needle Free Injectors
            6.6.3.2. Reusable Needle Free Injectors
   6.7. Conventional Drug Injection Devices
      6.7.1. By Reusability
            6.7.1.1. Disposable Injection Devices 
            6.7.1.2. Reusable Injection Devices 
      6.7.2. By Material
            6.7.2.1. Glass Based Injectors 
            6.7.2.2. Plastic Based Injectors
      6.7.3. By Drug Loading
            6.7.3.1. Prefilled Injection Devices 
            6.7.3.2. Fillable Injection Device
   6.8. Wearable injectors
   6.9. Safety syringes
   6.10. Integrated safety syringes
   6.11. Patch injectors
   6.12. Subcutaneous infusion devices
7. Global Injectable Drug Delivery Market – By Drug Formulations 
   7.1. Conventional Drug Delivery Formulations 
      7.1.1. Injectable Drug Delivery Formulation Solutions 
      7.1.2. Reconstituted Drug Delivery Formulation Solutions
   7.2. Novel Drug Delivery Formulation Solutions
      7.2.1. Liposomal Systems 
      7.2.2. Microspheres 
      7.2.3. Nanoparticles
      7.2.4. Polymeric Micelles
      7.2.5. Others
8. Global Injectable Drug Delivery Market - By Therapeutic Areas 
   8.1. Auto-Immune Diseases 
      8.1.1. Multiple Sclerosis 
      8.1.2. Rheumatoid Arthritis 
      8.1.3. Crohn's Diseases 
      8.1.4. Psoriasis 
      8.1.5. Others 
   8.2. Hormonal Disorders 
      8.2.1. Diabetes 
      8.2.2. Anemia 
      8.2.3. Reproductive Health Diseases 
      8.2.4. Osteoporosis 
      8.2.5. Growth Hormone Deficiency 
      8.2.6. Antithrombotic Therapy 
   8.3. Orphan or Rare Diseases 
   8.4. Oncology 
   8.5. Others 
      8.5.1. Pain Management 
      8.5.2. Hepatitis C 
      8.5.3. Allergies 
      8.5.4. Aesthetic Treatment
9. Global Injectable Drug Delivery Market-by application
   9.1. Diabetes
   9.2. Cardiovascular diseases
   9.3. Autoimmune diseases
   9.4. Hormones replacement
   9.5. Neurology addiction
   9.6. Respiratory diseases
   9.7. others
10. Global Injectable Drug Delivery Market- by end user
   10.1. Homecare
   10.2. Professional care
      10.2.1. Hospitals
      10.2.2. clinics
11. Global Injectable drug delivery Substrate Market - By Geography
   11.1. North America 
      11.1.1. U.S.  
      11.1.2. Canada 
      11.1.3. Mexico 
      11.1.4. Rest of North America
   11.2. South America 
      11.2.1. Brazil 
      11.2.2. Venezuela
      11.2.3. Argentina
      11.2.4. Ecuador
      11.2.5. Peru
      11.2.6. Colombia 
      11.2.7. Costa Rica
      11.2.8. Rest of South America
   11.3. Europe 
      11.3.1. U.K 
      11.3.2. Germany 
      11.3.3. Italy 
      11.3.4. France
      11.3.5. Netherlands
      11.3.6. Belgium
      11.3.7. Spain
      11.3.8. Denmark
      11.3.9. Rest of Europe
   11.4. APAC
      11.4.1. China 
      11.4.2. Australia 
      11.4.3. South Korea
      11.4.4. India
      11.4.5. Taiwan
      11.4.6. Malaysia
      11.4.7. Hong Kong  
      11.4.8. Rest of APAC
   11.5. Middle East& Africa 
      11.5.1. Israel
      11.5.2. South Africa
      11.5.3. Saudi Arabia
   11.6. Rest of Middle East and Africa
12. Market Entropy
   12.1. New Product Launches
   12.2. M&As, Collaborations, JVs, Partnership
13. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
   13.1. Baxter international
   13.2. Terumo Corp
   13.3. Schott AG
   13.4. SHL group
   13.5. Owen Mumford ltd
   13.6. Sanofi
   13.7. Novo nordix
   13.8. Company 8
   13.9. Company 9
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
14. Appendix
   14.1. Abbreviations
   14.2. Sources
   14.3. Research Methodology
   14.4. Bibliography
   14.5. Compilation of Expert Insights
   14.6. Disclaimer
The global injectable drug delivery market is $15.7B in 2017 and is estimated to grow at a CAGR of 8.53% during 2018-2023. Conventional injection devices holds the highest market share with 87% and generated revenue of 13.1B and is projected to grow with a CAGR of 7.37%. Changing healthcare models, a growing number of patients are driving the injectable drug delivery market.

What is Injectable drug delivery?
Injectable drug delivery is the injection of drugs in the patient’s body using a delivery device. With this it has become relatively easy allowing patients to administer drugs at home without medical assistance.

What are the major applications for Injectable drug delivery?
Injectable drug delivery is majorly used for different conditions that include hepatitis C, cystic fibrosis, pain, autoimmune diseases, Wilson’s disease, hormonal imbalance, hemophilia, and ribose-5-phosphate isomerase deficiency. It also helps in administering drugs in unconscious and comatose patients.



Market Research and Market Trends of Injectable drug delivery
  • Advancements in technological processes have resulted in the generation of improved and enhanced devices, as well as equipment that is tailor-made and specific to different categories of patient care. In addition, technological innovations like dual-injectable have further enhanced the method of drug delivery and the development of the biologics market has led to an increase in the demand for these injectable.
  • SmartDose platform is designed to easily integrate into a patient’s lifestyle. The single-use, electronic wearable injector stick to the patient’s body usually on the abdomen. It was designed for patient comfort and simplicity.
  • Component manufacturers continue to develop sophisticated packaging components and delivery systems to support the requirements of complex drug products. Drive toward cleaner and more secure primary containment systems that avoid interaction with the drug product and maintain the drug product's purity and effectiveness over time.

Who are the Major Players in Injectable drug delivery market?
The companies referred in the market research report includes Baxter international, Terumo Corp, Schott AG, SHL group, Owen Mumford ltd, Sanofi, Novo nordix.

What is our report scope?
The report incorporates in-depth assessment of the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis and so on to gauge the impact forces and potential opportunities of the market. Apart from this the report also includes a study of major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers and so on to comprehend the prevailing market dynamics at present and its impact during the forecast period 2018-2024.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report
  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
  • Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
  • Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes. 
  • Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years. 
  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market. 
List of Tables :

Table 1. Key Company Products, Conventional Injection Devices Market
Table 2. Key Company Products, Self-Injection Devices Market
Table 3. Key Company Products, Needle Free Injection Devices Market
Table 4. Key Company Products, Auto Injector Devices Market
Table 5. Key Company Products, Pen Injection Devices Market
Table 6. Global Diabetic Cases (Millions) and Prevelance Rates (%), 2011 and 2030
Table 7. Global Injectable Drug Delivery Devices Market, By Product, 2010 - 2018 ($Billion)
Table 8. Global Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 9. Global Self-Injection Devices Market, By Product, 2010 - 2018 ($Billion)
Table 10. Global Self-Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 11. Global Others Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 12. Global Auto Injectors Products Market, By Geography, 2010 - 2018 ($Million)
Table 13. Global Auto Injectors Market, By Drug Loading, 2010 - 2018 ($Million)
Table 14. Global Prefilled Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 15. Global Fillable Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 16. Global Auto Injectors Market, By User Intervention, 2010 - 2018 ($Million)
Table 17. Global Automated Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 18. Global Manual Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 19. Global Auto Injectors Market, By Design, 2010 - 2018 ($Million)
Table 20. Global Standardized Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 21. Global Customized Auto Injectors Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 22. Global Auto Injectors Market, By Reusability, 2010 - 2018 ($Million)
Table 23. Global Disposable Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 24. Global Reusable Auto Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 25. Global Pen Injector Market, By Geography, 2010 - 2018 ($Million)
Table 26. Global Pen Injectors Market, By Product, 2010 - 2018 ($Million)
Table 27. Global Single Chamber Pen Injector Market, By Geography, 2010 - 2018 ($Million)
Table 28. Global Dual Chamber Pen Injector Market, By Geography, 2010 - 2018 ($Million)
Table 29. Global Pen Injectors Market,By Reusability, 2010 - 2018 ($Million)
Table 30. Global Disposable Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 31. Global Reusable Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 32. Global Pen Injectors Market, By Design, 2010 - 2018 ($Million)
Table 33. Global Standard Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 34. Global Customized Pen Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 35. Global Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 36. Global Needle Free Injectors Market, By Drug Loading, 2010 - 2018 ($Million)
Table 37. Global Prefilled Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 38. Global Fillable Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 39. Global Needle Free Injectors Market, By Technology, 2010 - 2018 ($Million)
Table 40. Global Jet-Based Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 41. Global Spring-Based Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 42. Global Laser-Powered Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 43. Global Vibration-Based Needle Free Injector Market, By Geography, 2010 - 2018 ($Million)
Table 44. Global Needle Free Injectors Market, By Reusability, 2010 - 2018 ($Million)
Table 45. Global Disposable Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 46. Global Reusable Needle Free Injectors Market, By Geography, 2010 - 2018 ($Million)
Table 47. Global Conventional Injection Devices Market, By Reusability, 2010 - 2018 ($Billion)
Table 48. Global Disposable Conventional Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 49. Global Reusable Conventional Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 50. Global Conventional Injection Devices Market, By Material, 2010 - 2018 ($Billion)
Table 51. Global Glass Based Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 52. Global Plastics Based Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 53. Global Conventional Injection Devices Market, By Drug Loading, 2010 - 2018 ($Billion)
Table 54. Global Prefilled Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 55. Global Fillable Conventional Injection Devices Market, By Geography, 2010 - 2018 ($Billion)
Table 56. Global Injectable Drug Delivery Market, By Formulation Delivery Types, 2010 - 2018 ($Billion)
Table 57. Global Injectable Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Billion)
Table 58. Global Conventional Drug Delivery Formulations Market, By Dosage Form, 2010 – 2018 ($Billion)
Table 59. Global Conventional Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Billion)
Table 60. Global Injectable Conventional Drug Delivery Formulation Solutions, By Geography, 2010 - 2018 ($Billion)
Table 61. Global Reconstituted Conventional Drug Delivery Formulation Solutions, By Geography, 2010 - 2018 ($Billion)
Table 62. Global Novel Drug Delivery Formulations Market, By Delivery Systems, 2010 - 2018 ($Billion)
Table 63. Global Novel Drug Delivery Formulation Solutions Market, By Geography, 2010 - 2018 ($Billion)
Table 64. Global Liposomal Systems Based Drug Delivery Formulations, By Geography, 2010 - 2018 ($Million)
Table 65. Global Microspheres Based Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Million)
Table 66. Global Nanoparticles Based Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Million)
Table 67. Global Polymeric Micelles Based Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Million)
Table 68. Other Novel Drug Delivery Formulations Market, By Geography, 2010 - 2018 ($Billion)
Table 69. Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications, 2010 - 2018 ($Million)
Table 70. Global Auto-Immune Therapeutic Market, By Indication, 2010 - 2018 ($Million)
Table 71. Global Auto-Immune Therapeutic Market, By Geography, 2010 - 2018 ($Million)
Table 72. Global Multiple Sclerosis Market, By Geography, 2010 - 2018 ($Million)
Table 73. Global Rheumatoid Arthritis Market, By Geography, 2010 - 2018 ($Million)
Table 74. Global Crohn's Diseases Market, By Geography, 2010 - 2018 ($Million)
Table 75. Global Psoriasis Market, By Geography, 2010 - 2018 ($Million)
Table 76. Other Auto-Immune Diseases Market, By Geography, 2010 - 2018 ($Million)
Table 77. Global Hormonal Disorder Therapeutics Market, By Indication, 2010 - 2018 ($Million)
Table 78. Global Hormonal Disorders Therapeutics Market, By Geography, 2010 – 2018 ($Billion)
Table 79. Global Diabetes Therapeutics Market, By Geography, 2010 - 2018 ($Billion)
Table 80. Global Anemia Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 81. Global Reproductive Health Diseases Therapeutics Market, By Geography, 2010 - 2018($Million)
Table 82. Globalosteoporosis Therapeutics Market, By Geography, 2010 - 2018($Million)
Table 83. Global Growth Hormone Deficiency Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 84. Global Antithrombotic Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 85. Global Orphan/Rare Diseases Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 86. Global Oncology Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 87. Global Other Therapeutics Market, 2010 - 2018 ($Million)
Table 88. Global Other Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 89. Global Pain Management Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 90. Global Hepatitis C Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 91. Global Allergies Therapeutics Market, By Geography 2010 - 2018 ($Million)
Table 92. Global Aesthetic Treatment Therapeutics Market, By Geography, 2010 - 2018 ($Million)
Table 93. North America Injectable Drug Delivery Technologies Market,2010 - 2018 ($Billion)
Table 94. North America Injectable Drug Delivery Devices Market, By Segment, 2010 - 2018 ($Billion)
Table 95. North America Injectable Drug Delivery Formulation Solutions Market, 2010 - 2018 ($Billion)
Table 96. North America Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Billion)
Table 97. Europe Injectable Drug Delivery Technologies Market, 2010 - 2018 ($Billion)
Table 98. Europe Injectable Drug Delivery Devices Market, 2010 - 2018 ($Million)
Table 99. Europe Injectable Drug Delivery Formulation Solutions Market, By Segment, 2010 - 2018 ($Billion)
Table 100. Europe Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Billion)
Table 101. Asia Pacific Injectable Drug Delivery Technologies Market, By Segment,2010 - 2018 ($Billion)
Table 102. Asia Pacific Injectable Drug Delivery Devices Market, By Segment, 2010 - 2018 ($Million)
Table 103. Asia Pacific Injectable Drug Delivery Formulation Solutions Market, By Segment, 2010 - 2018 ($Billion)
Table 104. Asia Pacific Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Million)
Table 105. Rest of World Injectable Drug Delivery Technologies Market, By Segment, 2010 - 2018 ($Million)
Table 106. Rest of World Injectable Drug Delivery Devices Market, By Segment, 2010 - 2018 ($Million)
Table 107. Rest of World Injectable Drug Delivery Formulation Solutions Market, By Segment, 2010 - 2018 ($Million)
Table 108. Rest of World Injectable Drug Delivery Market, By Therapeutic Areas, 2010 - 2018 ($Million)
Table 109. Alkermes: Total Revenue and R&D Expenses,2011– 2013 ($Million)
Table 110. Alkermes: Total Revenue, By Geography, 2011 – 2013 ($Million)
Table 111. Antares Pharma: Total Revenue and R&D Expenses,2010– 2012 ($Million)
Table 112. Antares Pharma: Total Revenue, By Geography,2010 – 2012 ($Million)
Table 113. Antares Pharma: Total Revenue, By Product,2010 – 2012 ($Million)
Table 114. Baxter International: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 115. Baxter International: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 116. Baxter International: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 117. Baxter International: Medical Products Total Revenue, 2010 – 2012($Million)
Table 118. Becton Dickinson: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 119. Becton Dickinson: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 120. Becton Dickinson: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 121. Becton Dickinson: Medical Divsion Total Revenue,  2010 – 2012($Million)
Table 122. Consort Medical: Total Revenue and R&D Expenses, 2011– 2013 ($Million)
Table 123. Consort Medical: Total Revenue, By Geography, 2011 – 2013 ($Million)
Table 124. Eli Lilly & Co: Total Revenue and R&D Expenses,2010– 2012 ($Billion)
Table 125. Eli Lilly & Co: Total Revenue, By Geography,2010 – 2012 ($Billion)
Table 126. Eli Lilly & Co: Total Revenue, By Segment, 2010 – 2012 ($Billion)
Table 127. Gerresheimer Ag: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 128. Gerresheimer Ag: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 129. Gerresheimer Ag: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 130. Novo Nordisk: Total Revenue and R&D Expenses, 2010– 2012 ($Billion)
Table 131. Novo Nordisk: Total Revenue, By Geography, 2010 – 2012 ($Billion)
Table 132. Novo Nordisk: Total Revenue, By Segment, 2010 – 2012 ($Billion)
Table 133. Sanofi: Total Revenue and R&D Expenses, 2010– 2012 ($Billion)
Table 134. Sanofi: Total Revenue, By Geography, 2010 – 2012 ($Billion)
Table 135. Sanofi: Total Revenue, By Segment, 2010 – 2012 ($Billion)
Table 136. Schott Ag: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 137. Schott Ag: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 138. Terumo Corporation: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 139. Terumo Corporation: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 140. Terumo Corporation: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 141. Unilife Corporation: Total Revenue and R&D Expenses, 2011– 2013 ($Million)
Table 142. Unilife Corporation: Total Revenue, By Segment, 2011 – 2013 ($Million)
Table 143. West Pharma: Total Revenue and R&D Expenses, 2010– 2012 ($Million)
Table 144. West Pharma: Total Revenue, By Geography, 2010 – 2012 ($Million)
Table 145. West Pharma: Total Revenue, By Segment, 2010 – 2012 ($Million)
Table 146. Ypsomed: Total Revenue and R&D Expenses, 2011– 2012 ($Million)
Table 147. Ypsomed: Total Revenue, By Geography, 2011-2012 ($Million)
Table 148. Ypsomed: Total Revenue, By Segment, 2011 – 2012 ($Million)
Table 149. Zogenix, Inc.: Total Revenue and R&D Expenses, 2010– 2012 ($Million)

 
List of Figures:

Figure 1. Drug Injection Devices Segmentation
Figure 2. Drug Injection Formulations Segmentation
Figure 3. Drug Injection Formulations Segmentation
Figure 4. Global Conventional Injection Devices Market Share Analysis (%), 2012
Figure 5. Global Self-Injection Devices Market Share Analysis (%), 2012
Figure 6. Global Auto Injector Devices Market Share Analysis (%), 2012
Figure 7. Global Pen Injector Devices Market Share Analysis (%), 2012
Figure 8. Global Needle Free Injector Devices Market Share Analysis (%), 2012
Figure 9. Global Diabetes Market, By Treatment Methods (%), 2012 and 2018
Figure 10. Injectable Drug Delivery Devices, Value Chain Analysis
Figure 11. Drug Delivery Injection Devices – Product Segmentation
Figure 12. Global Injectable Drug Delivery Market, By Geography, 2013 (%)
Figure 13. Global IDD Market M&A's, Collaborations, Jv's & Partnerships, By Company (2013)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll